Skip to main contentSkip to navigation
Sirius Investors

Revenue Analysis - TOI

Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.

TOI Corporation

Annual

Revenue by Product Line

Latest quarterly revenue breakdown by product segments

Quarterly Product Revenue

Product Revenue Details

Detailed breakdown of revenue by product line

Health Care, Patient Service

0.0% of total revenue

$59.1M

Fee For Service

0.0% of total revenue

$32.2M

Capitated Revenue

0.0% of total revenue

$26.9M

Clinical Research Trials And Other Revenue

0.0% of total revenue

$813.0K

Historical Revenue Data

Quarterly product revenue breakdown over time (Last 6 records)

Date
Capitated Revenue
Clinical Research Trials And Other Revenue
Dispensary Revenue
Fee For Service
Health Care, Patient Service
3/31/2026$26.9M$813.0K$0$32.2M$59.1M
12/31/2025$44.1M$1.2M$0$75.9M$120.0M
6/30/2025$18.8M$1.3M$62.6M$37.0M$55.9M
3/31/2025$17.5M$2.0M$49.3M$35.6M$53.1M
12/31/2024$36.2M$4.1M$92.0M$66.5M$102.7M
9/30/2024$14.8M$1.9M$48.2M$34.9M$49.8M

Revenue Trend Analysis

Analysis of major growing and declining segments based on recent revenue data

Product Segments

Declining Segments
Fee For Service-57.6%
Health Care, Patient Service-50.8%
Capitated Revenue-39.0%

Earnings Reports

Want to see how TOI's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.

View Earnings Reports